Amarna and NorthX signing Henk Streefkerk and Janet Hoogstraate, CEO of Amarna and NorthX Biologicx respectively, at the ...

Advances in genetic cell modifications are performed routinely in research laboratories, but clinical translation requires ...

Nov. 29, 2024 — For pregnant women, exposure to fine particulate air pollution (PM2.5) was associated with altered immune responses that can lead to adverse birth outcomes, according to a new ...

This limits the wide impact of this study but can be used as a starting point to examine sex- and age differences in the transcriptome due to alternative splicing. Complex diseases often exhibit ...

The agency is also evaluating if there's a need for further regulatory action based on reports of hematologic malignancies from clinical trials of the therapy.

SPK-9001 is a novel, investigation vector containing a bio-engineered adeno-associated virus (AAV) capsid (protein shell) and a high-activity human coagulation FIX gene. The purpose of this gene ...

Exegenesis Bio, a clinical stage global gene therapy company is pleased to announce that US FDA has granted Orphan Drug Designation ("ODD") to EXG110, a novel gene therapy for Fabry disease, a rare ...

Introduction and Objectives Gene therapy for cystic fibrosis is approaching clinical trials. Using a lentiviral vector pseudotyped with Sendai virus fusion and hemagglutinin ... and measure protein ...

In this paper, a CRISPR-based gene addition strategy at the CX3CR1 locus of human hematopoietic stem cells is proposed to efficiently generate microglia engineered for the regulated expression of ...

The weekly shop in Brazil is a little different these days, and may soon change in other parts of the world plagued by dengue ...

Research collaboration by the Texas A&M Department of Entomology and the U.S. Department of Agriculture, USDA, creates ...